ZBED6 deficiency drives pathological cardiac hypertrophy through MEOX1–ERK1/2–dependent autophagy dysfunction
PLOS Genetics · 2026
DOI: 10.1371/journal.pgen.1012329 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Genetics, 2026. Verfasst von Xiao Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Animal Genetics, Breeding and Reproduction of Shaanxi Province, College of Animal Science and Technology, Northwest A&F University,…. Hauptthemen laut MEDLINE: Cardiomegaly, Autophagy, Repressor Proteins, Transcription Factors. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Technologies Research and Development Program, Key Science and Technology Program of Shaanxi Province.
Abstract (Originalsprache)
Pathological cardiac hypertrophy, a major risk factor for heart failure, is regulated by complex transcriptional networks. We previously identified the transcription factor ZBED6 as a key regulator for skeletal muscle hypertrophy, its role in the cardiac hypertrophy remains unexplored. Here, we report that ZBED6 is a key suppressor of pathological cardiac hypertrophy. ZBED6 is markedly reduced in myocardial tissues from patients with cardiac hypertrophy. ZBED6-deficient pigs exhibited cardiac hypertrophy with diastolic dysfunction. Integrative transcriptomic and ChIP-seq analyses identified MEOX1 as a direct negative target of ZBED6. Loss of ZBED6 upregulates MEOX1 transcription, which subsequently activated ERK1/2 signaling, leading to impaired autophagy-induced hypertrophy. Knockdown of MEOX1 reduced ERK1/2 phosphorylation and mitigated cardiomyocyte hypertrophy induced by ZBED6 deficiency. Similarly, pharmacological inhibition of ERK1/2 restored autophagy and alleviated hypertrophy in ZBED6-depleted cardiomyocytes. Collectively, these findings define a previously unrecognized ZBED6–MEOX1–ERK1/2 axis that critically regulates cardiac hypertrophy and represents a potential therapeutic target.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Animal Genetics, Breeding and Reproduction of Shaanxi Province, College of Animal Science and Technology, Northwest A&F University, Yangling, Shaanxi, China.
- Ultrasound in Cardiac Electrophysiology and Biomechanics Key Laboratory of Sichuan Province, Sichuan Provincial People's Hospital, University of Electronic Science and Technology of China, Chengdu, China.
- Clinical Immunology Translational Medicine Key Laboratory of Sichuan Province, Sichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital, Chengdu, Sichuan, China.
- Stomatology Hospital, School of Stomatology, Zhejiang University School of Medicine, Zhejiang Provincial Clinical Research Center for Oral Diseases, Key Laboratory of Oral Biomedical Research of Zhejiang Province, Engin…
ORCID-Profile: Xiaopeng Liu, Xiangkai Leng
Förderung
- Key Technologies Research and Development Program
- Key Science and Technology Program of Shaanxi Province
Zitieren
APA
Zhang, X., Liu, X., Pan, R., Liu, H., Xiao, J., Leng, X., Zhang, H., Pan, D., Duan, S., & Wu, J. (2026). ZBED6 deficiency drives pathological cardiac hypertrophy through MEOX1–ERK1/2–dependent autophagy dysfunction. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1012329
Vancouver
Zhang X, Liu X, Pan R, Liu H, Xiao J, Leng X, et al. ZBED6 deficiency drives pathological cardiac hypertrophy through MEOX1–ERK1/2–dependent autophagy dysfunction. PLOS Genetics. 2026. doi:10.1371/journal.pgen.1012329
BibTeX
@article{Zhang2026,
author = {Zhang, Xiao and Liu, Xiaopeng and Pan, Ruirui and Liu, Huan and Xiao, Junying and Leng, Xiangkai and Zhang, Hongmei and Pan, Dengke and Duan, Shengzhong and Wu, Jiangwei},
title = {ZBED6 deficiency drives pathological cardiac hypertrophy through MEOX1–ERK1/2–dependent autophagy dysfunction},
journal = {PLOS Genetics},
year = {2026},
doi = {10.1371/journal.pgen.1012329}
}
EUVIMED